Epitel
Latest round
- Series B
Last raised
- Jul 2026
Total raised
- $39M
Investors
- 7
About Epitel
Based in Utah, US, and founded in 2014 by CEO/CTO Mark Lehmkuhle, Epitel, Inc. operates as a digital health company that provides wearable devices that monitor patients' brain health. In July 2026, Epitel, Inc. Epitel, Inc. provides REMI (remote EEG monitoring platform), a wearable wireless ECG monitoring platform that is used to diagnose, treat, and manage seizures within hospital emergency rooms as well as critical care units. REMI is FDA approved product that is placed in the scalp below the hairline to capture EEG with 4 epilog sensors and connected with Persyst or an app to read EEG and receive seizure insights.
Who invested in Epitel
7 investors across 2 rounds
See all investors in Epitel
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Epitel
Who invested in Epitel?
Epitel has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epitel raised?
Epitel has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Epitel last raise money?
Epitel's most recent round on record is a Series B, in Jul 2026.
What does Epitel do?
Based in Utah, US, and founded in 2014 by CEO/CTO Mark Lehmkuhle, Epitel, Inc.
Where is Epitel headquartered?
Epitel is headquartered in Salt Lake City, US.
Which VCs invest in companies like Epitel?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Epitel's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Epitel? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.